Issue 3/2014
Content (24 Articles)
Breast edema in breast cancer patients following breast-conserving surgery and radiotherapy: a systematic review
Hanne Verbelen, Nick Gebruers, Tinne Beyers, Anne-Caroline De Monie, Wiebren Tjalma
AR collaborates with ERα in aromatase inhibitor-resistant breast cancer
Yassine Rechoum, Daniela Rovito, Domenico Iacopetta, Ines Barone, Sebastiano Andò, Nancy L. Weigel, Bert W. O’Malley, Powel H. Brown, Suzanne A. W. Fuqua
JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3
Liliang Li, Pan Gao, Yuhua Li, Yiwen Shen, Jianhui Xie, Daming Sun, Aimin Xue, Ziqin Zhao, Zude Xu, Mingchang Zhang, Beixu Li, Jieqing Jiang
An improved syngeneic orthotopic murine model of human breast cancer progression
Omar M. Rashid, Masayuki Nagahashi, Suburamaniam Ramachandran, Catherine Dumur, Julia Schaum, Akimitsu Yamada, Krista P. Terracina, Sheldon Milstien, Sarah Spiegel, Kazuaki Takabe
Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer
M. Tanioka, K. Sakai, T. Sudo, T. Sakuma, K. Kajimoto, K. Hirokaga, S. Takao, S. Negoro, H. Minami, K. Nakagawa, K. Nishio
Identification and translational validation of novel mammaglobin-A CD8 T cell epitopes
S. D. Soysal, S. Muenst, J. Kan-Mitchell, E. Huarte, X. Zhang, I. Wilkinson-Ryan, T. Fleming, V. Tiriveedhi, T. Mohanakumar, L. Li, J. Herndon, D. Oertli, S. P. Goedegebuure, W. E. Gillanders
Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells
Allison B. Haugrud, Yongxian Zhuang, Joseph D. Coppock, W. Keith Miskimins
Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China
Xinxin Zhu, Jianming Ying, Fang Wang, Jie Wang, Hongying Yang
Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel
C. Vulsteke, A. M. Pfeil, M. Schwenkglenks, R. Pettengell, T. D. Szucs, D. Lambrechts, M. Peeters, P. van Dam, A. S. Dieudonné, S. Hatse, P. Neven, R. Paridaens, H. Wildiers
High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer
Martin P. Nilsson, Linda Hartman, Ulf Kristoffersson, Oskar T. Johannsson, Åke Borg, Karin Henriksson, Elsa Lanke, Håkan Olsson, Niklas Loman
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer
Gayle S. Jameson, Emanuel F. Petricoin, Jasgit Sachdev, Lance A. Liotta, David M. Loesch, Stephen P. Anthony, Manpreet K. Chadha, Julia D. Wulfkuhle, Rosa I. Gallagher, Kimberley A. Reeder, Mariaelena Pierobon, Monica R. Fulk, Nina A. Cantafio, Bryant Dunetz, William D. Mikrut, Daniel D. Von Hoff, Nicholas J. Robert
Diagnostic accuracy of tactile imaging in selecting patients with palpable breast abnormalities: a prospective comparative study
Marios-Konstantinos Tasoulis, Konstantinos E. Zacharioudakis, Nikitas G. Dimopoulos, Dimitri J. Hadjiminas
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study
Patrizia Vici, Laura Pizzuti, Clara Natoli, Luca Moscetti, Lucia Mentuccia, Angela Vaccaro, Domenico Sergi, Luigi Di Lauro, Patrizia Trenta, Patrizia Seminara, Daniele Santini, Laura Iezzi, Nicola Tinari, Ilaria Bertolini, Valentina Sini, Marcella Mottolese, Diana Giannarelli, Francesco Giotta, Marcello Maugeri-Saccà, Maddalena Barba, Paolo Marchetti, Andrea Michelotti, Isabella Sperduti, Teresa Gamucci
Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage
Lu Chen, Hannah M. Linden, Benjamin O. Anderson, Christopher I. Li
Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?
Wilson Sheridan, Tyldesley Scott, Speers Caroline, Zheng Yvonne, Bernstein Vanessa, Voduc David, Gelmon Karen, Chia Stephen
Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine
George Dranitsaris, Mario E. Lacouture
Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses’ Health Study
Megan A. Healey, Rong Hu, Andrew H. Beck, Laura C. Collins, Stuart J. Schnitt, Rulla M. Tamimi, Aditi Hazra
Genome-wide DNA methylation profiling reveals parity-associated hypermethylation of FOXA1
Sagar Ghosh, Fei Gu, Chou-Miin Wang, Chun-Lin Lin, Joseph Liu, Howard Wang, Peter Ravdin, Yanfen Hu, Tim H. M. Huang, Rong Li
Neighborhood socioeconomic deprivation, tumor subtypes, and causes of death after non-metastatic invasive breast cancer diagnosis: a multilevel competing-risk analysis
Min Lian, Maria Pérez, Ying Liu, Mario Schootman, Ann Frisse, Ellen Foldes, Donna B. Jeffe
A study of ductal versus non-ductal invasive breast carcinomas in older women: long-term clinical outcome and comparison with their younger counterparts
J. Mathew, S. Lee, B. M. Syed, D. A. L. Morgan, I. O. Ellis, K. L. Cheung
Mesothelin expression is associated with poor outcomes in breast cancer
Yun R. Li, Rena R. Xian, Amy Ziober, Jose Conejo-Garcia, Alfredo Perales-Puchalt, Carl H. June, Paul J. Zhang, Julia Tchou
MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis
Filippo Santoro, Franca Podo, Francesco Sardanelli
Erratum to: MRI breast screening in high-risk women: cancer detection and survival analysis
D. Gareth Evans, Nisha Kesavan, Yit Lim, Soujanye Gadde, Emma Hurley, Nathalie J. Massat, Anthony J. Maxwell, Sarah Ingham, Rosalind Eeles, Martin O. Leach, Anthony Howell, Stephen W. Duffy